Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
Titel:
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
Auteur:
Wildiers, H. Fontaine, C. Vuylsteke, P. Martens, M. Canon, J. L. Wynendaele, W. Focan, C. Greve, J. De Squifflet, P. Paridaens, R.